{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:51:07Z","timestamp":1778737867339,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.euroneuro.2018.05.011","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T09:02:54Z","timestamp":1530262974000},"page":"925-932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Etifoxine impairs neither alertness nor cognitive functions of the elderly: A randomized, double-blind, placebo-controlled crossover study"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4995-584X","authenticated-orcid":false,"given":"D.","family":"Deplanque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Machuron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Waucquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Jozefowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Duhem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Somers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Colin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Duhamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bordet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2018.05.011_bib0001","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.eurpsy.2013.04.002","article-title":"Adjustment disorder with anxiety in old age: comparing prevalence and clinical management in primary care and mental health care","volume":"29","author":"Arbus","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0002","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2015.11.042","article-title":"A microPET comparison of the effects of etifoxine and diazepam on [11C]flumazenil uptake in rat brains","volume":"612","author":"Bouillot","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0003","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3344\/kjp.2015.28.1.4","article-title":"Etifoxine for pain patients with anxiety","volume":"28","author":"Choi","year":"2015","journal-title":"Korean J. Pain"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0004","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/fcp.12169","article-title":"Safety profile of etifoxine: a French pharmacovigilance survey","volume":"30","author":"Cottin","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0005","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/13803390500205718","article-title":"Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals","volume":"28","author":"Falleti","year":"2006","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0006","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0007","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0028-3908(03)00187-4","article-title":"The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the \u03b2 subunit","volume":"45","author":"Hamon","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0008","unstructured":"He, W., Goodkind, D., Kowal, P., 2016. U.S. Census Bureau, International Population Reports, P95\/16-1, An Aging World: 2015, U.S. Government Publishing Office, Washington, DC, 2016. Available from https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2016\/demo\/p95-16-1.pdf. Accessed 19.12.17."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0009","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000454881","article-title":"Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis","volume":"47","author":"Islam","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4306\/pi.2014.11.4.394","article-title":"A preliminary validity study of the cambridge neuropsychological test automated battery for the assessment of executive function in schizophrenia and bipolar disorder","volume":"11","author":"Kim","year":"2014","journal-title":"Psychiatry Invest."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0011","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00228-004-0808-2","article-title":"Patterns and correlates of benzodiazepine use in the French general population","volume":"60","author":"Lagnaoui","year":"2004","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0012","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.3399\/bjgp10X483922","article-title":"Psychotropic drug use among older people in general practice: discrepancies between opinion and practice","volume":"60","author":"Lasserre","year":"2010","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0013","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.psyneuen.2017.05.022","article-title":"Differential effects of the 18-kDa translocator protein (TSPO) ligand etifoxine on steroidogenesis in rat brain, plasma and steroidogenic glands: pharmacodynamic studies","volume":"83","author":"Liere","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0014","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.yebeh.2012.08.019","article-title":"Acute Loraz\u00e9pam effects on neurocognitive performance","volume":"25","author":"Loring","year":"2012","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0015","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/00004872-199917121-00005","article-title":"Use of computerized neuropsychological tests (CANTAB) to assess cognitive effects of antihypertensive drugs in the elderly","volume":"17","author":"Louis","year":"1999","journal-title":"J. Hypertens"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0016","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1472-8206.2001.00025.x","article-title":"A double blind parallel group placebo controlled comparison of sedative and mnesic effects of etifoxine and lorazepam in healthy subjects","volume":"15","author":"Micallef","year":"2001","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0017","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hup.757","article-title":"Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice","volume":"21","author":"Nguyen","year":"2006","journal-title":"Human Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40263-015-0305-4","article-title":"The benzodiazepine-dementia disorders link: current state of knowledge","volume":"30","author":"Pariente","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0019","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.2146\/ajhp160381","article-title":"Benzodiazepine use and cognitive decline in the elderly","volume":"75","author":"Picton","year":"2018","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pnpbp.2014.08.014","article-title":"Adverse performance effects of acute Loraz\u00e9pam administration in elderly long-term users: pharmacokinetic and clinical predictors","volume":"56","author":"Pomara","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0021","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/j.1532-5415.2005.00474.x","article-title":"Potential for alcohol and prescription drug interactions in older people","volume":"53","author":"Pringle","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0022","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1017\/S1355617798455073","volume":"4","author":"Robbins","year":"1998","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0023","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3922\/j.psns.2011.2.011","article-title":"The use of the Cambridge Neuropsychological Test Automated Battery (CANTAB) in neuropsychological assessment: application in Brazilian research with control children and adults with neurological disorders","volume":"4","author":"Roque","year":"2011","journal-title":"Psychol. Neurosci."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0024","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABA(A) receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Natl. Rev. Drug Discov"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0025","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0028-3908(99)00253-1","article-title":"Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine","volume":"39","author":"Schlichter","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0026","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/13803395.2013.771618","article-title":"A comparison of the Cambridge Automated Neuropsychological Test Battery (CANTAB) with \u201ctraditional\u201d neuropsychological testing instruments","volume":"35","author":"Smith","year":"2013","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0027","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12325-015-0176-6","article-title":"Etifoxine versus alprazolam for the treatment of adjustment disorder with anxiety: a randomized controlled trial","volume":"32","author":"Stein","year":"2015","journal-title":"Adv. Ther."},{"issue":"Suppl 2","key":"10.1016\/j.euroneuro.2018.05.011_bib0028","first-page":"9","article-title":"The effects of benzodiazepines on cognition","volume":"66","author":"Stewart","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0029","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","article-title":"Hooked on benzodiazepines: GABAA receptor subtypes and addiction","volume":"34","author":"Tan","year":"2011","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/0973-1229.58818","article-title":"The geriatric population and psychiatric medication","volume":"8","author":"Varma","year":"2010","journal-title":"Mens Sana Monogr."},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0031","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1097\/00001756-199910190-00015","article-title":"Interactions of etifoxine with the chloride channel coupled to the GABA(A) receptor complex","volume":"10","author":"Verleye","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.euroneuro.2018.05.011_bib0032","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0031-9384(04)00313-0","article-title":"Effects of etifoxine on stress-induced hyperthermia, freezing behavior and colonic motor activation in rats","volume":"82","author":"Verleye","year":"2004","journal-title":"Physiol. Behav."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18301263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18301263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,18]],"date-time":"2018-08-18T07:19:57Z","timestamp":1534576797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X18301263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0924977X18301263"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.05.011","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etifoxine impairs neither alertness nor cognitive functions of the elderly: A randomized, double-blind, placebo-controlled crossover study","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}